PT - JOURNAL ARTICLE AU - Sally Mortlock AU - Rosario I. Corona AU - Pik Fang Kho AU - Paul Pharoah AU - Ji-Heui Seo AU - Matthew L. Freedman AU - Simon A. Gayther AU - Matthew T. Siedhoff AU - Peter A.W. Rogers AU - Ronald Leuchter AU - Christine S. Walsh AU - Ilana Cass AU - Beth Y. Karlan AU - B.J. Rimel AU - Ovarian Cancer Association Consortium AU - International Endometriosis Genetics Consortium AU - Grant W. Montgomery AU - Kate Lawrenson AU - Siddhartha P. Kar TI - A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes AID - 10.1101/2021.06.28.21259290 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.28.21259290 4099 - http://medrxiv.org/content/early/2021/07/02/2021.06.28.21259290.short 4100 - http://medrxiv.org/content/early/2021/07/02/2021.06.28.21259290.full AB - Endometriosis is associated with increased risk of epithelial ovarian cancers (EOCs). Data from large endometriosis and EOC genome-wide association meta-analyses were used to estimate the genetic correlation and evaluate the causal relationship between genetic liability to endometriosis and major EOC histotypes, and to identify shared susceptibility loci. We estimated a significant genetic correlation (rg) between endometriosis and clear cell (rg=0.71), endometrioid (rg=0.48) and high-grade serous (rg=0.19) ovarian cancer, all supported by Mendelian randomization analyses. A bivariate meta-analysis identified 28 loci associated with endometriosis and EOC, including two novel risk loci, and 19 with evidence for a single underlying causal variant. Differences in the shared risk suggest different underlying pathways may contribute to the relationship between endometriosis and the different histotypes. Functional annotation using transcriptomic and epigenomic profiles of relevant tissues/cells highlighted several target genes. This comprehensive analysis reveals profound genetic overlap between endometriosis and EOC histotypes with valuable genomic targets for understanding the biological mechanisms linking the diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Health and Medical Research Council of Australia (GNT1026033, GNT1105321, GNT1147846, Investigator Grant 1177194 to G.W.M and Medical Research Future Fund Research Grant MRF1199785 to S.M) and National Institutes of Health (R01CA193910, R01CA204954, R01CA211707, R01CA251555). S.P.K is supported by a United Kingdom Research and Innovation Future Leaders Fellowship (MR/T043202/1). K.L. is supported by a Liz Tilberis Early Career Award (599175) and a Program Project Development (373356) from the Ovarian Cancer Research Alliance, plus a Research Scholars Grant from the American Society (134005). For funding details of the endometriosis meta-analysis please see Sapkota et al. (2017). For funding details of the ovarian cancer meta-analysis please see Phelan et al. (2017).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study includes no data deposited in external repositories.